Effect of Modified Poco-Poco Exercise to Aging Biomarkers in Elderly
Launched by UNIVERSITAS PADJADJARAN · Jun 19, 2025
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special type of exercise, called the modified Poco-Poco exercise, might help improve signs of aging in older adults who have sarcopenia—a condition where muscles become weak and smaller with age. The program will last for 12 weeks, and researchers want to see if this exercise can make a positive difference in muscle health and overall physical function.
People who are 60 years or older and have been diagnosed with sarcopenia may be eligible to join. However, those with hearing or vision problems that make it hard to follow instructions, serious joint or muscle problems, severe heart disease, or who are already taking part in another exercise program would not qualify. Participants will be asked to attend regular exercise sessions, and missing too many may mean they can no longer stay in the study. This trial is not yet recruiting, but it aims to offer a safe and guided way to help older adults improve their muscle strength and possibly slow down some effects of aging.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age above 60 years old
- • Have sarcopenia (based on AWGSOP 2019 criteria)
- Exclusion Criteria:
- • Hearing impairment/loss hindering participants to receive verbal instructions
- • Vision impairment/loss hindering participants to receive instructions
- • Musculoskeletal impairment or severe joint diseases (i.e. deformity in Osteoarthritis or Rheumatoid Arthritis)
- • Participants have been involved in other exercise program
- • Severe cardiovascular disease diagnosed by Cardiologist.
- • Participants will be excluded from the research if they skip 3 sessions of the program consecutively or skip 5 sessions cumulatively
About Universitas Padjadjaran
Universitas Padjadjaran, a prestigious academic institution in Indonesia, is dedicated to advancing medical research and clinical trials that contribute to the improvement of healthcare outcomes. With a strong emphasis on interdisciplinary collaboration and innovation, the university harnesses its extensive resources and expertise to conduct rigorous studies aimed at addressing pressing health challenges. Through its commitment to ethical research practices and community engagement, Universitas Padjadjaran plays a pivotal role in fostering evidence-based medicine and enhancing the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bandung, , Indonesia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported